Has the mortality of septic shock changed with time?

Critical Care Medicine

Volumn 26, Issue 12, 1998, Pages 2078-2086

  Friedman, Gilberto ^a   Silva, Eliézer ^a   Vincent, Jean Louis ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Gram negative organisms; Gram positive organisms; Mortality rates; Outcome; Source of infection

Indexed keywords

ABDOMINAL INFECTION; ARTICLE; GRAM NEGATIVE INFECTION; GRAM POSITIVE BACTERIUM; HUMAN; LUNG INFECTION; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; SEPTIC SHOCK; TREATMENT OUTCOME;

ADULT; AGE DISTRIBUTION; AGED; APACHE; FEMALE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; INTENSIVE CARE; MALE; MIDDLE AGED; SHOCK, SEPTIC; TIME FACTORS; WORLD HEALTH;

EID: 0032433470     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199812000-00045     Document Type: Article

References (144)

1. Parrillo JE, Parker MM, Natanson C, et al: Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 1990; 113:227-242
2. Vincent JL, Bihari D, Suter PM, et al: The prevalence of nosocomial infection in intensive care units in Europe - The results of the EPIC study. JAMA 1995; 274:639-644
3. Milberg JA, Davis DR, Steinberg KP, et al: Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993. JAMA 1995; 273:306-309
4. Weil MH, Spink WW: The shock syndrome associated with bacteremia due to Gram negative bacilli. Arch Intern Med 1958; 101:184-193
5. Altemeier WA, Cole WR: Gram negative bacteremia. Arch Surg 1958; 77:498-504
6. Spink WW: Endotoxin shock. Ann Intern Med 1962; 57:538-552
7. Weil MH, Shubin H, Biddle M: Shock caused by Gram-negative microorganisms. Ann Intern Med 1964; 60: 384-400
8. Wilson RF, Thal AP, Kindling PH: Hemodynamic measurements in septic shock. Arch Surg 1965; 91: 121-129
9. Loeb HS, Cruz A, Teng CY: Haemodynamic studies in shock associated with infection. Br Heart J 1967; 29:883-894
10. MacLean LD, Mulligan WG, McLean APH, et al: Patterns of septic shock in man - A detailed study of 56 patients. Ann Surg 1967; 166:543-559
11. Cavanagh D, Clark PJ, McLeod AGW: Septic shock of endotoxin type. Am J Obstet Gynecol 1968; 102:13-20
12. Skjoldborg H: Phenoxybenzamine in the treatment of septic shock. Acta Chir Scand 1968; 134:85-91
13. Ramirez-Soto E, Gonzalez-Loya JP, Valenzuela-Lopez S, et al: Treatment of bacteremic shock. Obstet Gynecol 1969; 33:409-417
14. McLaughlin JS, Suddhimondala C, Mech K: Pulmonary gas exchange in shock in humans. Ann Surg 1969; 169:42-56
15. Duff JH, Groves AC, McLean APH, et al: Defective oxygen consumption in septic shock. Surg Gynecol Obstet 1969; 128:1051-1060
16. Chalmers JP, Tiller DJ: Effects of treatment on the mortality rate in septicaemia. BMJ 1969; 2:338-341
17. Neely WA, Berry DW, Rushton FW, et al: Septic shock: Clinical, physiological, and pathological survey of 244 patients. N Engl J Med 1971; 173:657-666
18. Loeb HS, Winslow EBJ, Rahimtoola MB, et al: Acute hemodynamic effects of dopamine in patients with shock. Circulation 1971; 44:163-173
19. Wilson RF, Sarver EJ, Rizzo J: Hemodynamic changes, treatment, and prognosis in clinical shock. Arch Surg 1971; 102:21-24
20. Winslow EJ, Loeb HS, Rahimtoola SH, et al: Hemodynamic studies and results of therapy in 50 patients with bacteremic shock. Am J Med 1973; 54:421-432
21. Nishijima H, Weil MH, Herbert S, et al: Hemodynamic and metabolic studies on shock associated with Gram negative bacteremia. Medicine 1973; 52:287-294
22. McCabe WR: Serum complement levels in bacteremia due to Gram-negative organisms. N Engl J Med 1973; 288:21-23
23. Milligan GF, MacDonald JAE, Mellon A, et al: Pulmonary and hematologic disturbances during septic shock. Surg Gynecol Obstet 1974; 138:43-49
24. Chang P, Afifi AA, Liu VY, et al: Prognostic indices for assessment of patients with Gram-negative bacteremia and shock. An evaluation of hemodynamic, respiratory and metabolic parameters. In: Gram-Negative Bacterial Infections and Mode of Endotoxin Actions - Pathophysiological, Immunological, and Clinical Aspects. Urbaschek B, Urbaschek R, Neter E (Eds). New York, Springer-Verlag, 1975, pp 237-247
25. McArdle CS, MacDonald JAC, Ledingham M: A three year retrospective analysis of septic shock in a general hospital. Scott Med J 1975; 20:79-84
26. Degaute JP, Thys J, Cornil A: Le choc toxi-infectieux. Acta Chir Belg 1975; 3:245-265
27. Schumer W: Steroids in the treatment of clinical septic shock. Ann Surg 1976; 184:333-341
28. Scheckler WE: Septicemia in a community hospital 1970 through 1973. JAMA 1977; 237:1938-1941
29. Weisel R, Vito L, Dennis R, et al: Myocardial depression during sepsis. Am J Surg 1977; 133:510-521
30. Ledingham IM, McArdle CS: Prospective study of the treatment of septic shock. Lancet 1978; i:1194-1197
31. Shatney CH, Lillehei RC: Septic shock associated with operations for colorectal disease. Dis Colon Rectum 1978; 21:480-486
32. Wilson RF, Gibson D: The use of arterial central venous oxygen differences to calculate cardiac output and oxygen consumption in critically ill surgical patients. Surgery 1978; 84:362-369
33. Kreger BE, Craven DE, McCabe WR: Gram-negative bacteremia. Am J Med 1980; 68:344-355
34. Lucie NP, Browning DM, Smillie DM, et al: Platelet count and other haematological measurements in septic shock. J Clin Pathol 1980; 33:890
35. Vincent JL, Weil MH, Pun V, et al: Circulatory shock associated with purulent peritonitis. Am J Surg 1981; 142:262-270
36. Shoemaker WC, Appel P, Kram H: Clinical trial of an algorithm for outcome prediction in acute circulatory failure. Crit Care Med 1982; 10: 390-397
37. M'Belepe R, Mouton Y, Beaucaire G: A propos de cent quarante-cinq cas de pneumococcémie. Seminaires des Hôpitaux de Paris 1982; 58:310-315
38. Banks JG, Foulis AK, Ledingham IM, et al: Liver function in septic shock. J Clin Pathol 1982; 35:1249-1252
39. Ziegler EJ, McCutchan JA, Fierer J, et al: Treatment of Gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med 1982; 307:1225-1230
40. Pine WP, Wertz MJ, Lennard SE, et al: Determinations of organ malfunction or death in patients with intra-abdominal sepsis. Arch Surg 1983; 118:242-249
41. Weinstein MP, Murphy JR, Reller LB, et al: The clinical significance of positive blood cultures: A comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. Clinical observations, with special reference to factors influencing prognosis. Rev Infect Dis 1983; 5:54-70
42. Bohnen J, Boulanger M, Meakins JL, et al: Prognosis in generalized peritonitis. Arch Surg 1983; 118:285-290
43. Baumgartner JD, Vaney C, Perret C: An extreme form of the hyperdynamic syndrome in septic shock. Intensive Care Med 1984; 10:245-249
44. Sinanan M, Maier RV, Carrico CJ: Laparotomy for intra-abdominal sepsis in patients in an intensive care unit. Arch Surg 1984; 119:652-658
45. Abraham E, Bland R, Cobo J: Sequential cardiorespiratory patterns associated with outcome in septic shock. Chest 1984; 85:75-81
46. Sprung CL, Caralis PV, Marcial EH, et al: The effects of high-dose corticosteroids in patients with septic shock. N Engl J Med 1984; 311: 1137-1143
47. Lachman E, Pitsoe SB, Gaffin SL: Anti-lipopolysaccharide immunotherapy in management of septic shock of obstetric and gynecological origin. Lancet 1984; 1:981-983
48. Ellrodt AG, Riedinger MS, Kimchi A, et al: Left ventricular performance in septic shock: Reversible segmental and global abnormalities. Am Heart J 1985; 110:402-409
49. Haupt MT, Gilbert EM, Carlson RW: Fluid loading increases oxygen consumption in septic patients with lactic acidosis. Am Reu Respir Dis 1985; 131:912-916
50. Gilbert EM, Haupt MT, Mandanas RY, et al: The effect of fluid loading, blood transfusion and catecholamine infusion on oxygen delivery and consumption in patients with sepsis. Am Rev Respir Dis 1986; 134:873-878
51. Groeneveld AB, Bronsveld W, Thijs LG: Hemodynamic determinants of mortality in human septic shock. Surgery 1986; 99:140-152
52. Azimi G, Vincent JL: Ultimate survival from septic shock. Resuscitation 1986; 14:245-253
53. Ispahani P, Pearson NJ, Greenwood D: An analysis of community and hospital-acquired bacteraemia in a large teaching hospital in the United Kingdom. QJM 1987; 241:427-440
54. Groeneveld ABJ, Kester ADM, Nauta JJP: Relation of arterial blood lactate to oxygen delivery and hemodynamic variables in human shock states. Circ Shock 1987; 22:35-53
55. Bone RC, Fisher CJJ, Clemmer TP, et al: A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. W Engl J Med 1987; 317: 653-658
56. Parker MM, Shelhamer JH, Natanson C: Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: Heart rate as an early predictor of prognosis. Crit Care Med 1987; 15:923-929
57. Astiz ME, Rackow EC, Kaufman B, et al: Relationship of oxygen delivery and mixed venous oxygenation to lactic acidosis in patients with sepsis and acute myocardial infarction. Crit Care Med 1988; 16:655-658
58. Luce JM, Montgomery AB, Marks JD, et al: Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis 1988; 138:62-68
59. Reynolds HN, Haupt MT, Thill-Baharozian MC, et al: Impact of critical care physician staffing on patients with septic shock in a university hospital medical intensive care unit. JAMA 1988; 260:3446-3450
60. Rayner BL, Willcox PA: Community-acquired bacteraemia; a prospective survey of 239 cases. QJM 1988; 69:907-919
61. Calandra T, Glauser MP, Schellekens J, et al: Treatment of Gram-negative septic shock with human IgG antibody to Escherichia coli J5: A prospective, double-blind, randomized trial. J Infect Dis 1988; 158:312-319
62. Groeneveld AB, Nauta JJ, Thijs LG: Peripheral vascular resistance in septic shock: Its relation to outcome. Intensive Care Med 1988; 14:141-147
63. Tuchschmidt J, Fried J, Swinney R, et al: Early hemodynamic correlates of survival in patients with septic shock. Crit Care Med 1989; 17:719-723
64. Bone RC, Fisher CJ, Clemmer TP, et al: Sepsis syndrome: A valid clinical entity. Crit Care Med 1989; 17:389-393
65. Damas P, Reuter A, Gysen P, et al: Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 1989; 17: 975-979
66. Desjars P, Pinaud M, Bugnon D, et al: Norepinephrine therapy has no deleterious renal effects in human septic shock. Crit Care Med 1989; 17: 426-429
67. Pralong G, Calandra T, Glauser MP, et al: Plasminogen activator inhibitor 1: A new prognostic marker in septic shock. Thromb Haemost 1989; 61:459-462
68. Edwards JD, Brown GCS, Nightingale P, et al: Use of survivors' cardiorespiratory values as therapeutic goals in septic shock. Crit Care Med 1989; 17:1098-1103
69. Hack CE, Nuijens JH, Felt-Bersma RJF, et al: Elevated plasma levels of anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis. Am J Med 1989; 86:20-26
70. Safani M, Blair J, Ross D, et al: Prospective, controlled, randomized trial of naloxone infusion in early hyperdynamic septic shock. Crit Care Med 1989; 17:1004-1009
71. Vincent JL, Reuse C, Frank RN, et al: Right ventricular dysfunction in septic shock: Assessment by measurements of right ventricular ejection fraction using the thermodilution technique. Acta Anaesthesiol Scand 1989; 33:34-38
72. Parker MM, McCarthy KE, Ognibene FP, et al: Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest 1990; 97:126-131
73. D'Orio V, Mendes P, Saad G, et al: Accuracy in early prediction of prognosis of patients with septic shock by analysis of simple indices: Prospective study. Crit Care Med 1990; 18:1339-1345
74. Offner F, Philippe J, Vogelaers DP, et al: Serum tumor necrosis factor levels in patients with infectious disease and septic shock. J Lab Clin Med 1990; 116:100-105
75. Mecher CE, Rackow EC, Astiz ME, et al: Venous hypercarbia associated with severe sepsis and systemic hypoperfusion. Crit Care Med 1990; 18:585-589
76. Schein RM, Sprung CL, Marcial E, et al: Plasma cortisol levels in patients with septic shock. Crit Care Med 1990; 18:259-263
77. Marks JD, Marks CB, Luce JM, et al: Plasma tumor necrosis factor in patients with septic shock. Am Rev Respir Dis 1990; 141:94-97
78. Martin C, Saux P, Eon B, et al: Septic shock: A goal-directed therapy using volume loading, dobutamine and/or norepinephrine. Acta Anaesthesiol Scand 1990; 34:413-417
79. Schedel I, Dreikhausen U, Nentwig B: Treatment of Gram-negative septic shock with an immunoglobulin preparation: A prospective, randomized clinical trial. Crit Care Med 1991; 19:1104-1113
80. Ruokonen E, Takala J, Kari A, et al: Septic shock and multiple organ failure. Crit Care Med 1991; 19: 1146-1151
81. Ziegler EJ, Fisher CJ, Sprung CL, et al: Treatment of Gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. N Engl J Med 1991; 324:429-436
82. Ahmed AJ, Kruse JA, Haupt MT, et al: Hemodynamic responses to Gram-positive versus Gram-negative sepsis in critically ill patients with and without circulatory shock. Crit Care Med 1991; 19:1520-1525
83. Haupt MT, Jastremski MS, Clemmer TP, et al: Effects of ibuprofen in patients with severe sepsis: A randomized, double-bind, multicenter study. Crit Care Med 1991; 19:1339-1347
84. Greenman RL, Schein RMH, Martin MA, et al: A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of Gram-negative sepsis. JAMA 1991; 266:1097-1102
85. Danner RL, Elin RJ, Hosseini JM, et al: Endotoxemia in human septic shock. Chest 1991; 99:169-175
86. Bakker J, Coffernils M, Leon M, et al: Blood lactate levels are superior to oxygen derived variables in predicting outcome in human septic shock. Chest 1991; 99:956-962
87. Arregui LM, Moyes DG, Lipman J, et al: Comparison of disease severity scoring systems in septic shock. Crit Care Med 1991; 19:1165-1171
88. Calandra T, Gerain J, Heumann D, et al: High circulating levels of interleukin-6 in patients with septic shock: Evolution during sepsis, prognostic value, and interplay with other cytokines. Am J Med 1991; 91:23-29
89. Rothwell PM, Udwadia ZF, Lawler PG: Cortisol response to corticotropin and survival in septic shock. Lancet 1991; 337:582-583
90. Dofferhoff AS, Bom VJ, de Vries Hospers HG, et al: Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the treatment of severe sepsis in humans. Crit Care Med 1992; 20:185-192
91. Tuchschmidt J, Fried J, Astiz M, et al: Elevation of cardiac output and oxygen delivery improves outcome in septic shock. Chest 1992; 102: 216-220
92. Vincent JL, Gris P, Coffernils M, et al: Myocardial depression characterizes the fatal course of septic shock. Surgery 1992; 111:660-667
93. Nimmo GR, Mackenzie SJ, Walker SW, et al: The relationship of blood lactate concentrations, oxygen delivery and oxygen consumption in septic shock and the adult respiratory distress syndrome. Anaesthesia 1992; 47:1023-1028
94. Bakker J, Vincent JL, Gris P, et al: Veno-arterial carbon dioxide gradient in human septic shock. Chest 1992; 101:509-515
95. Baumgartner JD, Bula C, Vaney C, et al: A novel score for predicting the mortality of septic shock patients. Crit Care Med 1992; 20:953-960
96. Endo S, Inada K, Inoue Y, et al: Two types of septic shock classified by the plasma levels of cytokines and endotoxin. Circ Shock 1992; 38:264-274
97. Fourrier F, Chopin C, Goudemand J, et al: Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest 1992; 101:816-823
98. Moreau R, Hadengue A, Soupison T, et al: Septic shock in patients with cirrhosis: Hemodynamic and metabolic characteristics and intensive care unit outcome. Crit Care Med 1992; 20:746-750
99. Voerman HJ, Stehouwer CD, van Kamp GJ, et al: Plasma endothelin levels are increased during septic shock. Crit Care Med 1992; 20: 1097-1101
100. Shoemaker WC, Appel PL, Kram HB, et al: Temporal hemodynamic and oxygen transport patterns in medical patients. Septic shock. Chest 1993; 104:1529-1536
101. Martin C, Papazian L, Perrin G, et al: Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest 1993; 103:1826-1831
102. Redl-Wenzl EM, Armbruster C, Edelmann G, et al: The effects of norepinephrine on hemodynamics and renal function in severe septic shock states. Intensive Care Med 1993; 19:151-154
103. Pinsky MR, Vincent JL, Deviere J, et al: Serum cytokine levels in human septic shock: Relation to multiple-systems organ failure and mortality. Chest 1993; 103:565-575
104. Lorente JA, Landin L, De Pablo R, et al: L-arginine pathway in the sepsis syndrome. Crit Care Med 1993; 21:1287-1295
105. Marik PE: Gastric intramucosal pH. A better predictor of multiorgan dysfunction syndrome and death than oxygen-derived variables in patients with sepsis. Chest 1993; 104:225-229
106. Kieft H, Hoepelman AI, Zhou W, et al: The sepsis syndrome in a Dutch university hospital. Arch Intern Med 1993; 153:2241-2247
107. Shoemaker WC, Appel PL, Kram HB, et al: Sequence of physiologic patterns in surgical septic shock. Crit Care Med 1993; 21:1876-1889
108. Martin C, Saux P, Mege JL, et al: Prognostic values of serum cytokines in septic shock. Intensive Care Med 1994; 20:272-277
109. Froon AH, Bemelmans MH, Greve JW, et al: Increased plasma concentrations of soluble tumor necrosis factor receptors in sepsis syndrome: Correlation with plasma creatinine values. Crit Care Med 1994; 22: 803-809
110. Mathru M, Rooney MW, Dries DJ, et al: Urine hydrogen peroxide during adult respiratory distress syndrome in patients with and without sepsis. Chest 1994; 105:232-236
111. Matamis D, Tsagourias M, Koletsos K, et al: Influence of continuous haemofiltration-related hypothermia on haemodynamic variables and gas exchange in septic patients. Intensive Care Med 1994; 20:431-436
112. Hayes MA, Timmins AC, Yau EH, et al: Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994; 330:1717-1722
113. Fisher CJ, Dhainaut JF, Opal SM, et al: Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. JAMA 1994; 271:1836-1843
114. McCloskey RV, Straube RC, Sanders C, et al: Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1994; 121:1-5
115. Guidet B, Barakett V, Vassal T, et al: Endotoxemia and bacteremia in patients with sepsis syndrome in the intensive care unit. Chest 1994; 106:1194-1201
116. Spies CD, Reinhart K, Witt I, et al: Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: Results from a prospective, randomized, double blind study. Crit Care Med 1994; 22:1738-1746
117. Bouachour G, Tirot P, Gouello JP, et al: Adrenocortical function during septic shock. Intensive Care Med 1995; 21:57-62
118. Hannemann J, Reinhart K, Grenzer O, et al: Comparison of dopamine to dobutamine and norepinephrine for oxygen delivery and uptake in septic shock. Crit Care Med 1995; 23: 1962-1970
119. Dhainaut JF, Vincent JL, Richard C, et al: CDP571, a humanized antibody to human tumor necrosis factor-α: Safety, pharmacokinetics, immune response, and influence of the antibody on cytokine concentrations in patients with septic shock. Crit Care Med 1995; 23:1461-1469
120. Abraham E, Wunderink R, Silverman H, et al: Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. JAMA 1995; 273:934-941
121. Rangel-Frausto MS, Pittet D, Costigan M, et al: The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995; 273:117-123
122. Soni A, Pepper GM, Wyrwinski PM, et al: Adrenal insufficiency occurring during septic shock: Incidence, outcome and relationship to peripheral cytokine levels. Am J Med 1995; 98:266-271
123. Metrangolo L, Fiorillo M, Friedman G, et al: Early hemodynamic course of septic shock. Crit Care Med 1995; 23:1971-1975
124. Cohen J, Carlet J: INTERSEPT: An international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-α in patients with sepsis. Crit Care Med 1996; 24:1431-1440
125. Peake SL, Moran JL, Leppard PI: N-acetyl-cysteine depresses cardiac performance in patients with septic shock. Crit Care Med 1996; 24: 1302-1310
126. Neveu H, Kleinknecht D, Brivet F, et al: Prognostic factors in acute renal failure due to sepsis. Results of a prospective multicenter study. Nephrol Dial Transplant 1996; 11:293-299
127. Fisher CJ Jr, Agosti JM, Opal SM, et al: Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. N Engl J Med 1996; 334:1697-1702
128. Staudinger T, Presterl E, Graninger W, et al: Influence of pentoxifylline on cytokine levels and inflammatory parameters in septic shock. Intensive Care Med 1996; 22:888-893
129. Stegmayr BG: Plasmapheresis in severe sepsis or septic shock. Blood Purif 1996; 14:94-101
130. Krafft P, Fridrich P, Fitzgerald RD, et al: Effectiveness of nitric oxide inhalation in septic ARDS. Chest 1996; 109:486-493
131. Damas P, Canivet JL, de Groote D, et al: Sepsis and serum cytokine concentrations. Crit Care Med 1997; 25:405-412
132. Abraham E, Glauser MP, Butler T, et al: p55 tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. JAMA 1997; 19:1531-1538
133. Levy B, Bollaert PE, Charpentier C, et al: Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: A prospective, randomized study. Intensive Care Med 1997; 23:282-287
134. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions of sepsis and multiple organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874
135. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of disease classification system. Crit Care Med 1985; 13:818-829
136. Sibbald WJ, Vincent JL: Round table conference: Clinical trials in sepsis. Crit Care Med 1995; 23:294-399
137. Dhainaut JF, Tenaillon A, Le Tulzo Y, et al: Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: A randomized, double-blind, placebo-controlled, multicenter clinical trial. BN 52021 Sepsis Study Group. Crit Care Med 1994; 22:1720-1728
138. The National Committee for the Evaluation of Centoxin. The French national registry of HA-1A (Centoxin) in septic shock. A cohort study of 600 patients. Arch Intern Med 1994; 154:2484-2491
139. Gattinoni L, Brazzi L, Pelosi P, et al: A trial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 1995; 333:1025-1032
140. Barriere SL, Lowry SF: An overview of mortality risk prediction in sepsis. Crit Care Med 1995; 23:376-393
141. Marshall JC, Cook DJ, Christou NV, et al: Multiple organ dysfunction score: A reliable descriptor of a complex clinical outcome. Crit Care Med 1995; 23:1638-1652
142. Vincent JL, Moreno R, Takala J, et al: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996; 22:707-710
143. Bone RC: Gram-positive organisms and sepsis. Arch Intern Med 1994; 154:26-34
144. Schaberg DR, Culver DH, Gaynes RP: Major trends in the etiology of nosocomial infection. Am J Med 1991; 91(Suppl):72S-75S